Home Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia
Article
Licensed
Unlicensed Requires Authentication

Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia

  • Marie Bičíková , Daniela Řípová , Martin Hill , Roman Jirák , Helena Havlíková , Jaroslava Tallová and Richard Hampl
Published/Copyright: June 1, 2005

Abstract

Objective: The early differential diagnosis of Alzheimer's disease (AD) remains still problematic. We developed a laboratory test enabling us to distinguish patients with AD from those with vascular dementia (VD) and healthy subjects.

Methods: The AD group consisted of 22 women and 18 men. The VD group consisted of 16 women and 8 men. Age-matched controls consisted of 12 women and 9 men. Plasma pregnenolone sulfate (PregS), dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) were determined by radioimmunoassay. 17-Hydroxypregnenolone (17 Preg) and 7-hydroxylated metabolites of DHEA (7αDHEA, 7βDHEA) were determined by radioimmunoassay after separation by high performance liquid chromatography (HPLC). Homocysteine (Hcy), cysteine (Cys), cysteinylglycine (Cysgly) and glutathione (GSH) were measured by HPLC.

Results: The ANOVA results of significant between-group differences were as follows: The PregS and the 17-Preg and DHEAS levels were independent from the diagnosis. The 7αDHEA levels significantly depended on the sex (p<0.05) and diagnosis (p<0.01). Aminothiols were influenced by the diagnosis (p<0.01, p=0.0541, p<0.01 and p=0.0536 for Cys, Hcy, Cysgly and GSH, respectively). Using a stepwise backward regression analysis, the following parameters were obtained: X=11.5+4.03×sex+1.09× Hcy+0.190 × PregS−4.76×DHEAS+3.00×DHEA− 34.3×7αDHEA−0.885× Cysgly from which P-value as a discriminator was calculated according to the formula: P=1/(1+e−x). Then, for P>0.5, a subject was considered as AD-positive (with 89% correct prediction).

Discussion: The opportunity of early differential diagnosis of AD should help physicians to use suitable treatment for retardation of pathological processes.

Published Online: 2005-6-1
Published in Print: 2004-5-10

Copyright (c) 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Beyond cholesterol - inflammatory cytokines, the key mediators in atherosclerosis
  2. The emerging value of P-selectin as a disease marker
  3. Analysis of candidate genes in Polish families with obesity
  4. Detection of the Arg702Trp, Gly908Arg and Leu1007fsinsC polymorphisms of the NOD2/CARD15 gene by real-time PCR with melting curve analysis
  5. Up-regulation of reactive oxygen species (ROS) and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor
  6. Rapid detection of mutations in Wilson disease gene ATP7B by DNA strip technology
  7. Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin-induced oxidative damage to the blood and improves fetal outcomes in pregnant rats
  8. Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia
  9. Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status
  10. An International Standard for whole blood folate: evaluation of a lyophilised haemolysate in an international collaborative study
  11. Population-specific reference values for thyroid hormones on the Abbott ARCHITECT i2000 analyzer
  12. Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels
  13. Comparison of sensitivity and specificity of serum poly-C avid ribonuclease activity and C-reactive protein concentration in detection of mild and severe acute pancreatitis
  14. Emergency department triage of patients with acute chest pain: definition of cardiac troponin I decisional value to manage patients without electrocardiographic evidence of ischemia
  15. Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population
  16. The European Register for Specialists in Clinical Chemistry and Laboratory Medicine: Code ofConduct
  17. Decision cut-off of the polyethylene glycol precipitation technique in screening for macroprolactinemia on Immulite 2000
  18. No bias between the first and the new version of RIA for serum holo-transcobalamin by Axis-Shield
  19. Meetings and Awards
  20. SIBioC 2004: 36th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Padua, Italy, 8-11 June 2004
Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.088/html
Scroll to top button